-

Exactech Sharpens Focus on Technology with Active Intelligence®

Expansive Technology Platform Delivers Smart Solutions for Joint Replacement

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced today the launch of its Active Intelligence® platform of technologies that spans the entire journey of patient care. The company plans to aggressively expand its smart technology portfolio to better connect surgeons and patients with personalized, data-driven tools.

Active Intelligence defines Exactech’s strategic commitment to helping surgeons better engage with patients and peers, solve challenges with predictive tools and optimize how surgeons perform.

According to Exactech’s Chief Executive Officer Darin Johnson, “For more than 35 years, our company has focused on helping surgeons improve patient outcomes. With Active Intelligence, we are now expanding our strategic focus to deliver a comprehensive platform of uniquely accessible technologies to assist surgeons throughout the entire journey of patient care. Our practical solutions will help monitor patient recovery, connect surgeons and patients and unlock insights that will augment surgeons’ decision making in ways our industry has never seen.”

Exactech will unveil its pipeline of Active Intelligence solutions in the coming days and weeks. The platform builds on ExactechGPS®, the industry’s first and only no-capital-cost navigation system with verified implant placement guidance for both knee and shoulder surgery, and previously announced innovations including the Shoulder Planning App, the VERASENSE® shoulder sensor and the Vantage® Ankle Patient-Specific Instruments.

Exactech will introduce surgeons to Active Intelligence and unveil its near-term pipeline of innovations during a Dec. 3, 2020 webinar. Surgeons may register at www.exac.com/ActiveIntelligenceWebinar.

For more information about Active Intelligence, please visit www.ExactechAI.com.

*ExactechGPS® is manufactured by Blue Ortho and distributed by Exactech, Inc. VERASENSE™ is manufactured by OrthoSensor and distributed by Exactech, Inc.

About Exactech

Exactech is a global medical device company that develops and markets orthopaedic implant devices and related surgical instruments to hospitals and physicians. Exactech’s orthopaedic products and smart technologies are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases, such as arthritis. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit www.exac.com for more information and connect with us on LinkedIn, YouTube and Instagram.

Contacts

Priscilla Bennett, APR
Vice President of Marketing and Corporate Communications
(352) 377-1140

Exactech

Details
Headquarters: Gainesville, Fla.
Website: www.exac.com
CEO: Darin Johnson
Employees: 800
Organization: PRI

Release Versions

Contacts

Priscilla Bennett, APR
Vice President of Marketing and Corporate Communications
(352) 377-1140

More News From Exactech

Exactech Announces FDA 510(k) Clearance of the World’s First Surgical Navigation for Total Ankle Replacement

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced its subsidiary, BlueOrtho, has received 510(k) clearance from the Food and Drug Administration for ExactechGPS® Ankle, the world’s first surgical navigation system for total ankle arthroplasty (TAA). GPS Ankle is a first-of-its-kind technology, which connects the preoperative plan with real-time intraoperative instrument g...

Exactech Publishes New Machine Learning Research That Evaluates Fairness and Accuracy of AI Predictions

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, reports a new study1 that demonstrates its machine learning clinical decision support tool, Predict+™, creates fair and accurate outcomes predictions for shoulder arthroplasty patients of different ethnicity, sex and age. The study, the first of its kind in orthopaedics, has just been published in the Journal of Shoulder and Elbow...

Exactech AI Platform Surpasses 100,000 Joint Replacement Surgeries Worldwide

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today its Active Intelligence® (AI) platform surpassed more than 100,000 total joint replacement surgeries across the globe. “We are proud to reach this incredible milestone of more than 100,000 patients with the support of our surgeon partners worldwide,” said Exactech CEO Darin Johnson. “As a leader in orthopaedic innov...
Back to Newsroom